Impact Factor
3.93
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.73
729 total citations
h5-index
39
h5 depth signal
Cited share
79.4%
104 of 131
Total citations
729
Citation footprint
Metric signal
5.98
External metric anchor
Self-citation
2.1%
15 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
338
China
148
United Kingdom
85
Germany
65
France
42
Citing Fields of Research
Viral Identification & Phylogenetics
225
Genetics & Genomics
106
Stem Cell Biology
105
Immunology
85
Immunotherapy
78
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,710
Articles tracked across the journal lifetime
Indexed publication set
131
104 cited publications
Last 12 months
77
6.4 publications/month
Open access share
62.3%
48 OA publications in the last year
Leading citing country
United States
338 citing publications
Leading citing field
Viral Identification & Phylogenetics
225 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v1n1,Jan. 1994-
v1n1,Jan. 1994-
Active Coverage
Research Focus & Classification
Indexed Subjects
Viral Identification & Phylogenetics
Musculoskeletal Disorders
Genetics & Genomics
Ophthalmology
Neurodegenerative Disorders
Broad Categories
Genetics, Medical
Therapeutics
Viral Identification & Phylogenetics
MeSH Descriptors
Genetic Therapy
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1038/s41434-026-00652-y
Open DOI
Chronic lung infection does not impair lentiviral vector gene transfer in a cystic fibrosis rat model
Genetic therapies offer a promising strategy for treating cystic fibrosis (CF) lung disease, particularly for individuals with modulator-ineligible genotypes. However, clinical translation has been slower than anticipated. While CF gene ...
02
03
04
DOI 10.1038/s41434-026-00645-x
Open DOI
Local targeted suppression of neocortical spreading depolarization amplitude by viral expression of KCa3.1 channels
05
DOI 10.1038/s41434-026-00639-9
Open DOI
Rational selection of SpCas9 and variant-derived adenine base editors for human genome editing
Adenine base editors (ABEs), composed of Cas9 (i.e., SpCas9) nickase, adenosine deaminase, and sgRNA, can convert A•T base pairs to G•C base pairs in the genome without causing DNA double-strand breaks, thereby offering broad application...
06
DOI 10.1038/s41434-026-00643-z
Open DOI
Patient, consumer and societal values, perceptions and preferences on high-cost gene therapies
Novel cell and gene therapies hold great potential to alter the clinical course of a range of chronic diseases, yet uncertainties remain regarding their long-term efficacy and impact. These uncertainties pose challenges for Health Techno...
07
DOI 10.1038/s41434-026-00644-y
Open DOI
Intratumor delivery of a novel plasmid combination induces high levels of metastatic melanoma regression
08
DOI 10.1038/s41434-026-00642-0
Open DOI
Culture media alter retinal organoid physiology promoting AAV transduction and retinal ganglion cell survival
Human iPSC-derived retinal organoids offer a human-relevant platform for inherited retinal disease (IRD) gene therapy, yet robust AAV transduction in vitro remains challenging. Here we show that culture in BrainPhys™ (BP) medium markedly...
09
DOI 10.1038/s41434-026-00640-2
Open DOI
Optogenetic vision restoration: translational barriers and emerging therapeutic strategies
10
Bibliographical & Catalog Notes
Also issued online.
Vol. 1, no. 1 (JAN 1994)19960129 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper